Cullinan Therapeutics, Inc. (CGEM) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Cullinan Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.78x | -3.91x | -2.76x | 4.28x | -10.42x | -25.13x |
| P/B Ratio | 1.50x | 1.11x | 0.93x | 0.89x | 1.61x | 6.54x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 36.08x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | -358.7% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | -346.1% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | -358.4% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 10.25x | 13.53x | 17.07x | 21.09x | 25.25x | 14.82x |
| Quick Ratio | 10.25x | 13.53x | 17.07x | 21.09x | 25.25x | 14.82x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.00x | 0.01x | 0.01x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..